Glycemic Control Among People Living with Diabetes and Human Immunodeficiency Virus in Ethiopia: Leveraging Clinical Care for the Looming  Co-Epidemics

References

• Yoon C, Gulick RM, Hoover DR, Vaamonde CM, Glesby MJ. Case-control study of diabetes mellitus in HIV-infected patients. J Acquir Immune Defic Syndr. 2004;37(4):1464–1469. doi:10.1097/01.qai.0000137373.26438.18
   PubMedGoogle Scholar
• Guariguata L, de Beer I, Hough R, Mulongeni P, Feeley FG, de Wit TFR. Prevalence and knowledge assessment of HIV and non-communicable disease risk factors among formal sector employees in Namibia. PLoS One. 2015;10(7):e0131737. doi:10.1371/journal.pone.0131737
   PubMedGoogle Scholar
• Steiniche D, Jespersen S, Erikstrup C, et al. Diabetes mellitus and impaired fasting glucose in ART-naive patients with HIV-1, HIV-2 and HIV-1/2 dual infection in Guinea-Bissau: a cross-sectional study. Trans R Soc Trop Med Hyg. 2016;110(4):219–227. doi:10.1093/trstmh/trw017
   PubMed Web of Science ®Google Scholar
• Hadigan C, Kattakuzhy S. Diabetes mellitus type 2 and abnormal glucose metabolism in the setting of human immunodeficiency virus. Endocrinol Metab Clin. 2014;43(3):685–696. doi:10.1016/j.ecl.2014.05.003
   Google Scholar
• Njuguna B, Kiplagat J, Bloomfield GS, Pastakia SD, Vedanthan R, Koethe JR. Prevalence, risk factors, and pathophysiology of dysglycemia among people living with HIV in Sub-Saharan Africa. J Diabetes Res. 2018;2018:1–12. doi:10.1155/2018/6916497
   Google Scholar
• Fiseha T, Belete AG. Diabetes mellitus and its associated factors among human immunodeficiency virus-infected patients on antiretroviral therapy in Northeast Ethiopia. BMC Res Notes. 2019;12(1):372. doi:10.1186/s13104-019-4402-1
   PubMedGoogle Scholar
• Abebe SM, Getachew A, Fasika S, Bayisa M, Demisse AG, Mesfin N. Diabetes mellitus among HIV-infected individuals in follow-up care at University of Gondar Hospital, Northwest Ethiopia. BMJ Open. 2016;6(8):e011175. doi:10.1136/bmjopen-2016-011175
   PubMed Web of Science ®Google Scholar
• Ataro Z, Ashenafi W, Fayera J, Abdosh T. Magnitude and associated factors of diabetes mellitus and hypertension among adult HIV-positive individuals receiving highly active antiretroviral therapy at Jugal hospital, Harar, Ethiopia. HIV/AIDS. 2018;10:181.
   Google Scholar
• Capeau J, Bouteloup V, Katlama C, et al. Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment. Aids. 2012;26(3):303–314. doi:10.1097/QAD.0b013e32834e8776
   PubMed Web of Science ®Google Scholar
• De Wit S, Sabin CA, Weber R, et al. Incidence and risk factors for new-onset diabetes in HIV-infected patients: the data collection on adverse events of anti-HIV drugs (D: A: D) study. Diabetes Care. 2008;31(6):1224–1229. doi:10.2337/dc07-2013
   PubMed Web of Science ®Google Scholar
• Hadigan C, Meigs JB, Corcoran C, et al. Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis. 2001;32(1):130–139. doi:10.1086/317541
   PubMed Web of Science ®Google Scholar
• Samaras K. The burden of diabetes and hyperlipidemia in treated HIV infection and approaches for cardiometabolic care. Curr HIV/AIDS Rep. 2012;9(3):206–217. doi:10.1007/s11904-012-0124-x
   PubMedGoogle Scholar
• Feinstein MJ, Bahiru E, Achenbach C, et al. Patterns of cardiovascular mortality for HIV-infected adults in the United States: 1999 to 2013. Am J Cardiol. 2016;117(2):214–220. doi:10.1016/j.amjcard.2015.10.030
   PubMed Web of Science ®Google Scholar
• Miller CJ, Baker JV, Bormann AM, et al. Adjudicated morbidity and mortality outcomes by age among individuals with HIV infection on suppressive antiretroviral therapy. PLoS One. 2014;9(4):e95061. doi:10.1371/journal.pone.0095061
   PubMed Web of Science ®Google Scholar
• Palella FJ Jr, Baker RK, Moorman AC, et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr. 2006;43(1):27–34. doi:10.1097/01.qai.0000233310.90484.16
   PubMed Web of Science ®Google Scholar
• Epping-Jordan J, Bengoa R, Kawar R, Sabaté E. The challenge of chronic conditions: WHO responds: the sooner governments act, the better. BMJ. 2001;323(7319):947–948. doi:10.1136/bmj.323.7319.947
   PubMed Web of Science ®Google Scholar
• Melaku T, Chelkeba L, Mekonnen Z. Clinical care & blood pressure control among hypertensive people living with human immune deficiency virus: prospective cohort study. Ann Med Surg. 2020;54:114–124. doi:10.1016/j.amsu.2020.04.017
   PubMed Web of Science ®Google Scholar
• Saag MS. HIV Now Firmly Established in the Middle Ages. Oxford University Press; 2011.
   Google Scholar
• Carr A. HIV protease inhibitor-related lipodystrophy syndrome. Clin Infect Dis. 2000;30(Supplement_2):S135–S42.
   PubMedGoogle Scholar
• Opwora A, Waweru E, Toda M, et al. Implementation of patient charges at primary care facilities in Kenya: implications of low adherence to user fee policy for users and facility revenue. Health Policy Plan. 2014;30(4):508–517.
   PubMedGoogle Scholar
• Eckhardt BJ, Holzman RS, Kwan CK, Baghdadi J, Aberg JA. Glycated hemoglobin A1C as screening for diabetes mellitus in HIV-infected individuals. AIDS Patient Care STDS. 2012;26(4):197–201. doi:10.1089/apc.2011.0379
   PubMed Web of Science ®Google Scholar
• Kim PS, Woods C, Georgoff P, et al. A1C underestimates glycemia in HIV infection. Diabetes Care. 2009;32(9):1591–1593. doi:10.2337/dc09-0177
   PubMed Web of Science ®Google Scholar
• Glesby MJ, Hoover DR, Shi Q, et al. Glycated hemoglobin in diabetic women with and without HIV infection: data from the women’s interagency HIV study. Antivir Ther. 2010;15(4):571. doi:10.3851/IMP1557
   PubMedGoogle Scholar
• Venables E, Edwards JK, Baert S, Etienne W, Khabala K, Bygrave H. “ They just come, pick and go.” The acceptability of integrated medication adherence clubs for HIV and non-communicable disease (NCD) patients in Kibera, Kenya. PLoS One. 2016;11(10):e0164634.
   PubMedGoogle Scholar
• Organization WH. Prevention and Control of Noncommunicable Diseases: Guidelines for Primary Health Care in Low Resource Settings. World Health Organization; 2012.
   Google Scholar
• Organization WH. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach. World Health Organization; 2016.
   Google Scholar
• Hoerger TJ, Segel JE, Gregg EW, Saaddine JB. Is glycemic control improving in US adults? Diabetes Care. 2008;31(1):81–86. doi:10.2337/dc07-1572
   PubMed Web of Science ®Google Scholar
• Adeyemi O, Vibhakar S, Max B. Are we meeting the American diabetes association goals for HIV-infected patients with diabetes mellitus? Clin Infect Dis. 2009;49(5):799–802. doi:10.1086/605286
   PubMed Web of Science ®Google Scholar
• Bury JE, Stroup JS, Stephens JR, Baker DL, editors. Achieving American diabetes association goals in HIV-seropositive patients with diabetes mellitus. In: Baylor University Medical Center Proceedings. Taylor & Francis; 2007.
   Google Scholar
• Agha RA, Borrelli MR, Vella-Baldacchino M, et al. The STROCSS statement: strengthening the reporting of cohort studies in surgery. Int J Surg. 2017;46:198–202. doi:10.1016/j.ijsu.2017.08.586
   PubMed Web of Science ®Google Scholar
• Riley L, Guthold R, Cowan M, et al. The World Health Organization STEPwise approach to noncommunicable disease risk-factor surveillance: methods, challenges, and opportunities. Am J Public Health. 2016;106(1):74–78. doi:10.2105/AJPH.2015.302962
   PubMed Web of Science ®Google Scholar
• Toobert DJ, Hampson SE, Glasgow RE. The summary of diabetes self-care activities measure: results from 7 studies and a revised scale. Diabetes Care. 2000;23(7):943–950. doi:10.2337/diacare.23.7.943
   PubMed Web of Science ®Google Scholar
• Sharoni SKA, Wu SFV. Self‐efficacy and self‐care behavior of Malaysian patients with type 2 diabetes: a cross-sectional survey. Nurs Health Sci. 2012;14(1):38–45. doi:10.1111/j.1442-2018.2011.00658.x
   PubMed Web of Science ®Google Scholar
• Choi EJ, Nam M, Kim SH, et al. Psychometric properties of a Korean version of the summary of diabetes self-care activities measure. Int J Nurs Stud. 2011;48(3):333–337. doi:10.1016/j.ijnurstu.2010.08.007
   PubMedGoogle Scholar
• Adarmouch L, Sebbani M, Elyacoubi A, Amine M. Psychometric properties of a moroccan version of the summary of diabetes self-care activities measure. J Diabetes Res. 2016;2016:1–6. doi:10.1155/2016/5479216
   Google Scholar
• Association AD. Glycemic targets: standards of medical care in diabetes-2019. Diabetes Care. 2019;42(Suppl1):S61.
   PubMedGoogle Scholar
• Valderas JM, Starfield B, Sibbald B, Salisbury C, Roland M. Defining comorbidity: implications for understanding health and health services. Ann Fam Med. 2009;7(4):357–363. doi:10.1370/afm.983
   PubMed Web of Science ®Google Scholar
• Alberti KGMM, Zimmet P, Shaw J. Metabolic syndrome—a new world‐wide definition. A consensus statement from the international diabetes federation. Diabet Med. 2006;23(5):469–480. doi:10.1111/j.1464-5491.2006.01858.x
   PubMed Web of Science ®Google Scholar
• Obesity N, Heart N, Lung Institute B, Initiative NOE. The Practical Guide: Identification, Evaluation, and Treatment of Overweight and obesity in Adults. National Institutes of Health, National Heart, Lung, and Blood Institute; 2000.
   Google Scholar
• Khattab M, Khader YS, Al-Khawaldeh A, Ajlouni K. Factors associated with poor glycemic control among patients with type 2 diabetes. J Diabetes Complications. 2010;24(2):84–89. doi:10.1016/j.jdiacomp.2008.12.008
   PubMed Web of Science ®Google Scholar
• Eid M, Mafauzy M, Faridah A. Glycaemic control of type 2 diabetic patients on follow up at Hospital Universiti Sains Malaysia. Malays J Med Sci. 2003;10(2):40.
   PubMedGoogle Scholar
• Gopinath B, Sri Sai Prasad M, Jayarama N, Prabhakara K. Study of factors associated with poor glycemic control in type 2 diabetic patients. Glob J Med Public Health. 2013;2(2):1–5.
   Google Scholar
• Satlin MJ, Hoover DR, Glesby MJ. Glycemic control in HIV-infected patients with diabetes mellitus and rates of meeting American diabetes association management guidelines. AIDS Patient Care STDS. 2011;25(1):5–12. doi:10.1089/apc.2010.0237
   PubMed Web of Science ®Google Scholar
• Chu C, Umanski G, Blank A, Meissner P, Grossberg R, Selwyn PA. Comorbidity-related treatment outcomes among HIV-infected adults in the Bronx, NY. J Urban Health. 2011;88(3):507–516. doi:10.1007/s11524-010-9540-7
   PubMedGoogle Scholar
• Roerink M, Meijering R, Bosch M, de Galan B, van Crevel R. Diabetes in patients with HIV: patient characteristics, management and screening. Neth J Med. 2015;73(7):310–315.
   PubMedGoogle Scholar
• Pillay S, Aldous C, Mahomed F. A deadly combination–HIV and diabetes mellitus: where are we now? S Afr Med J. 2016;106(4):378–383. doi:10.7196/SAMJ.2016.v106i4.9950
   Google Scholar
• Davies ML, Johnson MD, Brown JN, Bryan WE, Townsend ML. Predictors of glycaemic control among HIV-positive veterans with diabetes. Int J STD AIDS. 2015;26(4):262–267. doi:10.1177/0956462414535207
   PubMed Web of Science ®Google Scholar
• Fazekas-Lavu M, Tonks KT, Samaras K. Benchmarks of diabetes care in men living with treated HIV-infection: a tertiary center experience. Front Endocrinol (Lausanne). 2018;9:634. doi:10.3389/fendo.2018.00634
   PubMedGoogle Scholar
• Ledergerber B, Furrer H, Rickenbach M, et al. Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV cohort study. Clin Infect Dis. 2007;45(1):111–119. doi:10.1086/518619
   PubMed Web of Science ®Google Scholar
• Lundgren JD, Battegay M, Behrens G, et al. European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV. HIV Med. 2008;9(2):72–81. doi:10.1111/j.1468-1293.2007.00534.x
   PubMed Web of Science ®Google Scholar
• da Cunha J, Maselli LMF, Stern ACB, Spada C, Bydlowski SP. Impact of antiretroviral therapy on lipid metabolism of human immunodeficiency virus-infected patients: old and new drugs. World J Virol. 2015;4(2):56. doi:10.5501/wjv.v4.i2.56
   PubMedGoogle Scholar
• Adeyemi O, Rezai K, Bahk M, Badri S, Thomas-Gossain N. Metabolic syndrome in older HIV-infected patients: data from the CORE50 cohort. AIDS Patient Care STDS. 2008;22(12):941–945. doi:10.1089/apc.2008.0119
   PubMedGoogle Scholar
• Alencastro PR, Fuchs SC, Wolff FH, Ikeda ML, Brandão AB, Barcellos NT. Independent predictors of metabolic syndrome in HIV-infected patients. AIDS Patient Care STDS. 2011;25(11):627–634. doi:10.1089/apc.2010.0360
   PubMedGoogle Scholar
• Alvarez C, Salazar R, Galindez J, et al. Metabolic syndrome in HIV-infected patients receiving antiretroviral therapy in Latin America. Braz J Infect Dis. 2010;14(3):256–263. doi:10.1016/S1413-8670(10)70053-2
   PubMedGoogle Scholar
• Feleke SA, Alemayehu CM, Adane HT, Onigbinde A, Akindoyi O, Faremi F. Assessment of the level and associated factors with knowledge and practice of diabetes mellitus among diabetic patients attending at FelegeHiwot hospital, Northwest Ethiopia. Clin Med Res. 2013;2(6):110. doi:10.11648/j.cmr.20130206.11
   Google Scholar
• Ayele K, Bisrat Tesfa LA, Tilahun T, Girma E. Self care behavior among patients with diabetes in Harari, Eastern Ethiopia: the health belief model perspective. PLoS One. 2012;7(4).
   Google Scholar
• Maina WK, Ndegwa ZM, Njenga EW, Muchemi EW. Knowledge, attitude and practices related to diabetes among community members in four provinces in Kenya: a cross-sectional study. Pan Afr Med J. 2010;7(1).
   Google Scholar
• Bonger Z, Shiferaw S, Tariku EZ. Adherence to diabetic self-care practices and its associated factors among patients with type 2 diabetes in Addis Ababa, Ethiopia. Patient Prefer Adherence. 2018;12:963. doi:10.2147/PPA.S156043
   PubMed Web of Science ®Google Scholar
• Tewahido D, Berhane Y. Self-care practices among diabetes patients in Addis Ababa: a qualitative study. PLoS One. 2017;12(1). doi:10.1371/journal.pone.0169062
   PubMedGoogle Scholar
• Rao P. Persons with type 2 diabetes and co-morbid active tuberculosis should be treated with insulin. Int J Diabetes Dev Ctries. 1999;19:79–86.
   Google Scholar
• Sadiya A, Mnla R. Impact of food pattern on glycemic control among type 2 diabetic patients: a cross-sectional study in the United Arab Emirates. Diabetes Metab Syndr Obes. 2019;12:1143.
   PubMed Web of Science ®Google Scholar
• Du H, Li L, Bennett D, et al. Fresh fruit consumption in relation to incident diabetes and diabetic vascular complications: a 7-y prospective study of 0.5 million Chinese adults. PLoS Med. 2017;14(4):e1002279. doi:10.1371/journal.pmed.1002279
   PubMed Web of Science ®Google Scholar
• Carter P, Gray L, Talbot D, Morris D, Khunti K, Davies M. Fruit and vegetable intake and the association with glucose parameters: a cross-sectional analysis of the let’s prevent diabetes study. Eur J Clin Nutr. 2013;67(1):12–17. doi:10.1038/ejcn.2012.174
   PubMed Web of Science ®Google Scholar
• Muraki I, Imamura F, Manson JE, et al. Fruit consumption and risk of type 2 diabetes: results from three prospective longitudinal cohort studies. BMJ. 2013;347(aug28 1):f5001. doi:10.1136/bmj.f5001
   PubMedGoogle Scholar
• Montonen J, Järvinen R, Heliövaara M, Reunanen A, Aromaa A, Knekt P. Food consumption and the incidence of type II diabetes mellitus. Eur J Clin Nutr. 2005;59(3):441–448. doi:10.1038/sj.ejcn.1602094
   PubMed Web of Science ®Google Scholar
• Tanaka S, Yoshimura Y, Kawasaki R, et al. Fruit intake and incident diabetic retinopathy with type 2 diabetes. Epidemiology. 2013;204–211.
   PubMedGoogle Scholar
• Wang PY, Fang JC, Gao ZH, Zhang C, Xie SY. Higher intake of fruits, vegetables or their fiber reduces the risk of type 2 diabetes: a meta‐analysis. J Diabetes Investig. 2016;7(1):56–69. doi:10.1111/jdi.12376
   PubMed Web of Science ®Google Scholar
• Christensen AS, Viggers L, Hasselström K, Gregersen S. Effect of fruit restriction on glycemic control in patients with type 2 diabetes–a randomized trial. Nutr J. 2013;12(1):29. doi:10.1186/1475-2891-12-29
   PubMedGoogle Scholar
• Association AD. Standards of medical care in diabetes—2015: summary of revisions. Am Diabetes Assoc. 2015.
   Google Scholar
• Maritim A, Sanders A, Watkins J III. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol. 2003;17(1):24–38. doi:10.1002/jbt.10058
   PubMed Web of Science ®Google Scholar
• Sievenpiper JL, de Souza RJ, Jenkins DJ. Sugar: fruit fructose is still healthy. Nature. 2012;482(7386):470.
   PubMedGoogle Scholar
• Sinclair AJ, Armes DG, Randhawa G, Bayer AJ. Caring for older adults with diabetes mellitus: characteristics of carers and their prime roles and responsibilities. Diabet Med. 2010;27(9):1055–1059. doi:10.1111/j.1464-5491.2010.03066.x
   PubMed Web of Science ®Google Scholar
• Marchesi JR, Adams DH, Fava F, et al. The gut microbiota and host health: a new clinical frontier. Gut. 2016;65(2):330–339. doi:10.1136/gutjnl-2015-309990
   PubMed Web of Science ®Google Scholar
• Cai X, Hu D, Pan C, et al. The risk factors of glycemic control, blood pressure control, lipid control in Chinese patients with newly diagnosed type 2 diabetes a nationwide prospective cohort study. Sci Rep. 2019;9(1):1–14. doi:10.1038/s41598-019-44169-4
   PubMedGoogle Scholar
• Bae J, Lage M, Mo D, Nelson D, Hoogwerf B. Obesity and glycemic control in patients with diabetes mellitus: analysis of physician electronic health records in the US from 2009–2011. J Diabetes Complications. 2016;30(2):212–220. doi:10.1016/j.jdiacomp.2015.11.016
   PubMedGoogle Scholar
• El-Kebbi IM, Cook CB, Ziemer DC, Miller CD, Gallina DL, Phillips LS. Association of younger age with poor glycemic control and obesity in urban African Americans with type 2 diabetes. Arch Intern Med. 2003;163(1):69–75. doi:10.1001/archinte.163.1.69
   PubMedGoogle Scholar
• Martins RA, Jones JG, Cumming SP, e Silva MJC, Teixeira AM, Veríssimo MT. Glycated hemoglobin and associated risk factors in older adults. Cardiovasc Diabetol. 2012;11(1):13. doi:10.1186/1475-2840-11-13
   PubMedGoogle Scholar
• Babikr WG, Alshahrani ASA, Hamid HGM, Abdelraheem AHMK, Shalayel MHF. The Correlation of HbA1c with Body Mass Index and HDL-Cholesterol in Type 2 Diabetic Patients. 2016.
   Google Scholar
• Wojtaszewski J, Hansen BF, Kiens B, Markuns J, Goodyear L, Richter E. Insulin signaling and insulin sensitivity after exercise in human skeletal muscle. Diabetes. 2000;49(3):325–331. doi:10.2337/diabetes.49.3.325
   PubMedGoogle Scholar
• El-Kebbi IM, Ziemer DC, Cook CB, Miller CD, Gallina DL, Phillips LS. Comorbidity and glycemic control in patients with type 2 diabetes. Arch Intern Med. 2001;161(10):1295–1300. doi:10.1001/archinte.161.10.1295
   PubMedGoogle Scholar
• Piette JD, Kerr EA. The impact of comorbid chronic conditions on diabetes care. Diabetes Care. 2006;29(3):725–731. doi:10.2337/diacare.29.03.06.dc05-2078
   PubMed Web of Science ®Google Scholar
• Haghighatpanah M, Nejad ASM, Haghighatpanah M, Thunga G, Mallayasamy S. Factors that correlate with poor glycemic control in type 2 diabetes mellitus patients with complications. Osong Public Health Res Perspect. 2018;9(4):167. doi:10.24171/j.phrp.2018.9.4.05
   PubMedGoogle Scholar
• Sanal T, Nair N, Adhikari P. Factors associated with poor control of type 2 diabetes mellitus: a systematic review and meta-analysis. J Diabetol. 2011;3(1):1–10.
   Google Scholar
• Sasi ST, Kodali M, Burra KC, Muppala BS, Gutta P, Bethanbhatla MK. Self care activities, diabetic distress and other factors which affected the glycaemic control in a tertiary care teaching hospital in South India. J Clin Diagn Res. 2013;7(5):857.
   PubMedGoogle Scholar
• Kakade AA, Mohanty IR, Sandeep R. Assessment of factors associated with poor glycemic control among patients with type II diabetes mellitus. Integr Obes Diabetes. 2018;4(3).
   Google Scholar
• Ali T, Sindhu Kaitha SM, Ftesi A, Stone J, Bronze MS. Clinical use of anti-TNF therapy and increased risk of infections. Drug Healthc Patient Saf. 2013;5:79. doi:10.2147/DHPS.S28801
   PubMedGoogle Scholar
• Pamungkas RA, Hadijah S, Mayasari AN, Nusdin N. Factors associated with poor glycemic control among type 2 diabetes mellitus in Indonesia. Belitung Nurs J. 2017;3(3):272–280. doi:10.33546/bnj.61
   Google Scholar
• Niazi AK, Kalra S. Diabetes and tuberculosis: a review of the role of optimal glycemic control. J Diabetes Metab Disord. 2012;11(1):28. doi:10.1186/2251-6581-11-28
   PubMedGoogle Scholar
• Baghaei P, Marjani M, Javanmard P, Tabarsi P, Masjedi MR. Diabetes mellitus and tuberculosis facts and controversies. J Diabetes Metab Disord. 2013;12(1):58. doi:10.1186/2251-6581-12-58
   PubMedGoogle Scholar
• Young F, Wotton C, Critchley J, Unwin N, Goldacre M. Increased risk of tuberculosis disease in people with diabetes mellitus: record-linkage study in a UK population. J Epidemiol Community Health. 2012;66(6):519–523. doi:10.1136/jech.2010.114595
   PubMedGoogle Scholar
• Oluboyo P, Erasmus R. The significance of glucose intolerance in pulmonary tuberculosis. Tubercle. 1990;71(2):135–138. doi:10.1016/0041-3879(90)90010-6
   PubMedGoogle Scholar
• Basoglu O, Bacakoglu F, Cok G, Saymer A, Ates M. The oral glucose tolerance test in patients with respiratory infections. Monaldi Arch Chest Dis. 1999;54:307–310.
   PubMedGoogle Scholar
• Ruslami R, Aarnoutse RE, Alisjahbana B, Van Der Ven AJ, Van Crevel R. Implications of the global increase of diabetes for tuberculosis control and patient care. Trop Med Int Health. 2010;15(11):1289–1299. doi:10.1111/j.1365-3156.2010.02625.x
   PubMed Web of Science ®Google Scholar
• Holman R, Turner R, Pickup J, Williams G. Textbook of Diabetes. Oxford: Blackwell; 1991:467–469.
   Google Scholar
• Jeon CY, Harries AD, Baker MA, et al. Bi‐directional screening for tuberculosis and diabetes: a systematic review. Trop Med Int Health. 2010;15(11):1300–1314. doi:10.1111/j.1365-3156.2010.02632.x
   PubMed Web of Science ®Google Scholar
• Wang M-C, Cervantes J. Glycemic control in tuberculosis: lessons learned from Taiwan. Asian Pac J Trop Med. 2019;12(10):438.
   Google Scholar
• Lee P-H, Fu H, Lai T-C, Chiang C-Y, Chan -C-C, Lin -H-H. Glycemic control and the risk of tuberculosis: a cohort study. PLoS Med. 2016;13(8):e1002072. doi:10.1371/journal.pmed.1002072
   PubMed Web of Science ®Google Scholar
• Martinez L, Zhu L, Castellanos ME, et al. Glycemic control and the prevalence of tuberculosis infection: a population-based observational study. Clin Infect Dis. 2017;65(12):2060–2068. doi:10.1093/cid/cix632
   PubMed Web of Science ®Google Scholar
• Dobler CC, Flack JR, Marks GB. Risk of tuberculosis among people with diabetes mellitus: an Australian nationwide cohort study. BMJ Open. 2012;2(1):e000666. doi:10.1136/bmjopen-2011-000666
   PubMed Web of Science ®Google Scholar
• Gurukartick J, Murali L, Shewade HD, et al. Glycemic control monitoring in patients with tuberculosis and diabetes: a descriptive study from programmatic setting in Tamil Nadu, India. F1000Research. 2019;8(1725):1725. doi:10.12688/f1000research.20781.1
   PubMedGoogle Scholar
• Amrit G, Ashok S. Tuberculosis and diabetes: an appraisal. Indian J Tuberc. 2000;47(1):3–8.
   Google Scholar
• Demoz GT, Gebremariam A, Yifter H, et al. Predictors of poor glycemic control among patients with type 2 diabetes on follow-up care at a tertiary healthcare setting in Ethiopia. BMC Res Notes. 2019;12(1):207. doi:10.1186/s13104-019-4248-6
   PubMedGoogle Scholar
• Kautzky‐Willer A, Kosi L, Lin J, Mihaljevic R. Gender‐based differences in glycaemic control and hypoglycaemia prevalence in patients with type 2 diabetes: results from patient‐level pooled data of six randomized controlled trials. Diabetes Obes Metab. 2015;17(6):533–540. doi:10.1111/dom.12449
   PubMedGoogle Scholar
• Mauvais-Jarvis F. Gender differences in glucose homeostasis and diabetes. Physiol Behav. 2018;187:20–23. doi:10.1016/j.physbeh.2017.08.016
   PubMed Web of Science ®Google Scholar
• Arnetz L, Ekberg NR, Alvarsson M. Sex differences in type 2 diabetes: focus on disease course and outcomes. Diabetes Metab Syndr Obes. 2014;7:409. doi:10.2147/DMSO.S51301
   PubMedGoogle Scholar